Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-000831
Filing Date
2018-02-15
Accepted
2018-02-15 15:56:04
Documents
6
Period of Report
2018-03-12
Effectiveness Date
2018-02-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2234555zdef14a.htm DEF 14A 3109189
2 G30192CAI001.GIF g30192cai001.gif GRAPHIC 160466
3 G30192CAI002.GIF g30192cai002.gif GRAPHIC 120764
4 G440222.JPG g440222.jpg GRAPHIC 28032
5 G534329.JPG g534329.jpg GRAPHIC 11540
6 G833231.JPG g833231.jpg GRAPHIC 6401
  Complete submission text file 0001047469-18-000831.txt   3561459
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36714 | Film No.: 18617613
SIC: 2834 Pharmaceutical Preparations